The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 12, 2009, Pages 1550-1556

  Aliberti, S ^a,b   Brock, G N ^c   Peyrani, P ^b   Blasi, F ^a   Ramirez, Julio A ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cancer, pneumonia severity index; Clinical research; Community acquired pneumonia; CRB 65

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CRB 65 SCORING SYSTEM; DATA BASE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 74949111923     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mandell L A, Wunderink R G, Anzueto A, et al.; Infectious Diseases Society of America/American Thoracic Society. Consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27-S72.
2. Fine M J, Auble T E, Yealy D M, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
3. Lim W S, Lewis S, Macfarlane J T. Severity prediction rules in community-acquired pneumonia: a validation study. Thorax 2000; 55: 219-223.
4. Lim W S, van der Eerden M M, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
5. Macfarlane J, Boswell T, Douglas G. BTS guidelines for management of community-acquired pneumonia in adults - 2004 update. London, UK: British Thoracic Society, 2004. http://www.brit-thoracic.org.uk/Portals/0/ Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf Accessed September 2009.
6. Capelastegui A, España P P, Quintana J M, et al. Validation of a predictive rule for the management of community acquired pneumonia. Eur Respir J 2006; 27: 151-157.
7. Bauer T T, Ewig S, Marre R, Suttorp N, Weite T; the CAP-NETZ Study Group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93-101.
8. Mayaud C, Cadranel J. A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host. Thorax 2000; 55: 511-517.
9. Collin B A, Ramphal R. Pneumonia in the compromised host including cancer patients and transplant patients. Infect Dis Clin North Am 1998; 12: 781-805.
10. Pizzo P A. Fever in immunocompromised patients. N Engl J Med 1999; 341: 893-900.
11. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487.
12. Rañó A, Agustí C, Benito N, et al. Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2002; 122: 253-261.
13. Sanders K M, Marras T K, Chan C K. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13: 89-93.